2 unknown, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Recruiting 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Antirheumatic Agents: new trials by email Literature Review of Antirheumatic Agents trials Research Report on Antirheumatic Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| L-carnitine Supplementation in Rheumatoid Arthritis Patients Carnitine, Disease-modifying anti-rheumatic drugs - Rheumatoid Arthritis (RA) | Phase 2 | Recruiting | German University in Cairo | 60 | 2024-12-31 | 2025-01-07 |
| Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs), Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs), UC-MSC+DMARDS - Rheumatoid Arthritis | Phase 1 / Phase 2 | Unknown | Alliancells Bioscience Corporation Limited | 200 | 2013-04-01 | 2013-06-27 |
| New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis interferon-gamma, infliximab, dmard - Reactive Arthritis | Phase 2 | Unknown | Charite University, Berlin, Germany | 40 | 2003-01-01 | 2006-09-08 |
Arthritis, Rheumatoid (2) · Arthritis, Reactive (1) · Bronchiolitis Obliterans Syndrome (1)
Alliancells Bioscience Corporation Limited (1) · Charite University, Berlin, Germany (1) · German University in Cairo (1)
China (1) · Egypt (1) · Germany (1)
Haijie Ji, MD (1) · Liming Wang, MD (1) · Mingyuan Wu, MD,PhD (1) · Yongjun Liu, MD,PhD (1)